Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.227 EUR | +2.48% | -1.30% | -81.90% |
Apr. 22 | Mithra Pharmaceuticals Obtains Court Protection Measures | MT |
Mar. 08 | Mithra Pharmaceuticals SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2023 | 40.16M 42.97M | Sales 2024 * | 43.9M 46.98M | Capitalization | 15.69M 16.79M |
---|---|---|---|---|---|
Net income 2023 | -174M -186M | Net income 2024 * | -55M -58.86M | EV / Sales 2023 | 9.88 x |
Net Debt 2023 | 310M 332M | Net Debt 2024 * | 166M 178M | EV / Sales 2024 * | 4.15 x |
P/E ratio 2023 * |
-0.16
x | P/E ratio 2024 * |
-
| Employees | 270 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 81.67% |
1 day | +2.48% | ||
1 week | -1.30% | ||
Current month | -18.64% | ||
1 month | -5.42% | ||
3 months | -79.77% | ||
6 months | -79.55% | ||
Current year | -81.90% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 17-02-22 | |
Stijn Vlaminck
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Graham Dixon
CTO | Chief Tech/Sci/R&D Officer | 63 | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jacques Galloy
BRD | Director/Board Member | 53 | 23-05-28 |
Christian Homsy
CHM | Chairman | 65 | 23-05-28 |
Valérie Gordenne
BRD | Director/Board Member | 51 | 21-05-19 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.227 | +2.48% | 44,805 |
24-04-22 | 0.2215 | -1.12% | 120,811 |
24-04-19 | 0.224 | -3.86% | 63,556 |
24-04-18 | 0.233 | +5.67% | 36,373 |
24-04-17 | 0.2205 | -4.55% | 184,870 |
Real-time Euronext Bruxelles, April 23, 2024 at 11:35 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-81.90% | 16.29M | |
-2.68% | 85.68B | |
+4.08% | 41.4B | |
-25.35% | 28.22B | |
+54.31% | 24.64B | |
-4.52% | 16.98B | |
-42.09% | 13.29B | |
-17.77% | 11.66B | |
-12.10% | 11.65B | |
+0.75% | 8.18B |
- Stock Market
- Equities
- MITRA Stock